Big pharmaceutical companies watching their pipelines dry up might want to give Evotec a call. The drug discovery and development firm partners with larger drug companies to discover new compounds and bring them into clinical trials. Its capabilities include assay development, screening, and medicinal chemistry. Evotec has broad collaborations with Roche and Boehringer Ingelheim to find therapies for diseases of the central nervous system (CNS), its area of expertise. It also has a pipeline of preclinical and clinical CNS drugs of its own; it intends to find partners to take on development of the drugs in late-stage clinical trials.